Dr. Troy Rohn has been on the faculty at Boise State University since 2000. He graduated in 1990 from the University of California at Davis with a B.S. in Physiology, and received his Ph.D. in Pharmacology from the University of Washington, Seattle, in 1994. His interests include the role of apoptosis in neurodegenerative diseases. Dr. Rohn had several Postdoctoral stints including two plus years living in Paris, France, one year at Montana State University in Bozeman, Montana, and two years at UC Irvine at the Institute of Brain Aging and Dementia under the direction of Dr. Carl Cotman. Dr. Rohn continues to collaborate extensively with UC Irvine and more specifically with Dr. Elizabeth Head. He has obtained extramural funding continuously since his arrival at BSU including grants from NIH, AFAR and most recently from AHAF.
Articles
Depletion of Beclin-1 Due to Proteolytic Cleavage by Caspases in the Alzheimer's Disease Brain (with Ellen Wirawan, Raquel J. Brown, Jordan R. Harris, Eliezer Masliah, and Peter Vandenabeele), Neurobiology of Disease (2011)
The Beclin-1 protein is essential for the initiation of autophagy and recent studies suggest this...
Immunolocalization of Influenza A Virus and Markers of Inflammation in the Human Parkinson’s Disease Brain (with Lindsey W. Catlin), PloS ONE (2011)
Although much is known regarding the molecular mechanisms leading to neuronal cell loss in Parkinson’s...
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease, PLoS ONE (2011)
Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are common causes of motor and...
The Role of Caspases in Alzheimer's Disease; Potential Novel Therapeutic Opportunities, Apoptosis (2010)
Although apoptosis plays a critical role in molding the CNS into its final appearance and...
Caspase-Cleaved TAR DNA-Binding Protein-43 in Parkinson’s Disease and Dementia with Lewy Bodies (with Polina Kokoulina), Neurodegenerative Diseases (2010)
Background: TAR DNA-binding protein-43 (TDP-43) proteinopathies are classified based upon the extent of modified TDP-43...
Presentations